The broad, long-term objective of this proposal is to elucidate the pathogenesis for the familial cardiomyopathy caused by the missense mutation in alphaB-crystallin (alphaBC) chaperone and to develop potential therapeutic strategies for similar cardiovascular disorders involving mutant proteins. Results of recent genetic analysis have established that a substitution of glycine for arginine at position 120 (Argl20Gly R120G) in the alphaB-crystallin protein causes an inheritable multisystem disorder leading to congestive heart failure and premature death. Presently, the nature of the unifying mechanism(s) and the pathogenesis of this cardiomyopathy is unknown. The hypothesis to be tested is that protein misfolding and aggregation of human alphaB-crystallin mutation (glycine yields arginine substitution at position 120, alphaBCR120G) are causal factors in the pathogenesis of the cardiomyopathy through effects that disorganize the cytoskeleton and impair contractile performance.
Specific aims i nclude: (1) Determine whether aggregate formation, a hallmark of the disease in the myocardium, is caused by protein misfolding and alphaB-crystallinR120G expression as a dominant defective allele; (2) Determine whether or not expression of human alphaB-crystallin gene alphaBC R120G impairs cardiac bioenergetics and increases ventricular dysfunction in the intact heart as assessed noninvasively using NMR spectroscopy, cardiac echocardiogram, and MRI imaging; (3) determine: (a) whether accumulation of the mutant alphaB-crystallinR120G protein evokes a bona fide 'unfolded protein response' and upregulation of the HSP family of stress 'heat shock' proteins, and (b) whether the posttranslational modifications affect mutant alphaB- crystallinR120G protein degradation. Our studies will employ transgenic and gene knock-out models of the alphaB-crystallin chaperone and the heat shock transcription factor. Results of this study should help elucidate the mechanisms by which the alphaB-crystallinR120G mutation causes cardiomyopathy. Evidence that endogenous protective mechanisms such as the HSP family of stress proteins can mitigate against or retard alphaB-crystallinR120G cardiomyopathy could have major implications for treatment of cardiovascular diseases involving either inherited or acquired genetic errors.
|Grose, Julianne H; Langston, Kelsey; Wang, Xiaohui et al. (2015) Characterization of the Cardiac Overexpression of HSPB2 Reveals Mitochondrial and Myogenic Roles Supported by a Cardiac HspB2 Interactome. PLoS One 10:e0133994|
|Hussein, Rasha M; Benjamin, Ivor J; Kampinga, Harm H (2015) Rescue of ?B Crystallin (HSPB5) Mutants Associated Protein Aggregation by Co-Expression of HSPB5 Partners. PLoS One 10:e0126761|
|Banerjee Mustafi, Soumyajit; Grose, Julianne H; Zhang, Huali et al. (2014) Aggregate-prone R120GCRYAB triggers multifaceted modifications of the thioredoxin system. Antioxid Redox Signal 20:2891-906|
|Christians, Elisabeth S; Mustafi, Soumyajit B; Benjamin, Ivor J (2014) Chaperones and cardiac misfolding protein diseases. Curr Protein Pept Sci 15:189-204|
|Xie, Heng B; Cammarato, Anthony; Rajasekaran, Namakkal S et al. (2013) The NADPH metabolic network regulates human ?B-crystallin cardiomyopathy and reductive stress in Drosophila melanogaster. PLoS Genet 9:e1003544|
|Brewer, Alison C; Mustafi, Soumyajit Banerjee; Murray, Thomas V A et al. (2013) Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease. Antioxid Redox Signal 18:1114-27|
|Limphong, Pattraranee; Zhang, Huali; Christians, Elisabeth et al. (2013) Modeling human protein aggregation cardiomyopathy using murine induced pluripotent stem cells. Stem Cells Transl Med 2:161-6|
|Zhang, Huali; Limphong, Pattraranee; Pieper, Joel et al. (2012) Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity. FASEB J 26:1442-51|
|Benjamin, Ivor J (2012) Targeting endoglin, an auxiliary transforming growth factor ? coreceptor, to prevent fibrosis and heart failure. Circulation 125:2689-91|
|Christians, Elisabeth S; Benjamin, Ivor J (2012) Proteostasis and REDOX state in the heart. Am J Physiol Heart Circ Physiol 302:H24-37|
Showing the most recent 10 out of 18 publications